We are live on ! Find out more
VTYX

Ventyx Biosciences

Delisted

VTYX was delisted on the 3rd of March, 2026.

1 hedge funds and large institutions have $21K invested in Ventyx Biosciences in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

73.19% less ownership

Funds ownership: 73.19%0% (-73%)

99% less funds holding

Funds holding: 1391 (-138)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 138

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $472M → $21K (-$472M)

Holders
1
Holders Change
-138
Holders Change %
-99.28%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
138
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
51
Barclays
United Kingdom
-$1.07M -118,702 Closed
EI
52
EAM Investors
California
-$1.01M -111,398 Closed
Hudson Bay Capital Management
53
Hudson Bay Capital Management
Connecticut
-$924K -102,357 Closed
BC
54
Birchview Capital
Vermont
-$910K -100,827 Closed
Squarepoint
55
Squarepoint
New York
-$899K -99,559 Closed
American Century Companies
56
American Century Companies
Missouri
-$898K -99,499 Closed
SAM
57
Sectoral Asset Management
Quebec, Canada
-$875K -96,945 Closed
HighTower Advisors
58
HighTower Advisors
Illinois
-$776K -85,972 Closed
ACM
59
ADAR1 Capital Management
Texas
-$737K -81,600 Closed
SEI Investments
60
SEI Investments
Pennsylvania
-$711K -78,703 Closed
JF
61
Jump Financial
Illinois
-$688K -76,200 Closed
UBS Group
62
UBS Group
Switzerland
-$616K -68,216 Closed
XT
63
XTX Topco
Cayman Islands
-$608K -67,361 Closed
LCM
64
Landscape Capital Management
New Jersey
-$519K -57,437 Closed
Citigroup
65
Citigroup
New York
-$509K -56,344 Closed
PAP
66
Persistent Asset Partners
Hong Kong
-$484K -53,642 Closed
ECM
67
ExodusPoint Capital Management
New York
-$452K -50,009 Closed
ATPW
68
Ashton Thomas Private Wealth
Arizona
-$436K -48,316 Closed
VPIM
69
Vanguard Personalized Indexing Management
California
-$420K -46,561 Closed
LPL Financial
70
LPL Financial
California
-$415K -46,005 Closed
GT
71
Glenmede Trust
Pennsylvania
-$380K -42,055 Closed
LPC
72
Lion Point Capital
New York
-$375K -41,500 Closed
SSA
73
Schonfeld Strategic Advisors
New York
-$361K -40,027 Closed
VCIM
74
Velan Capital Investment Management
Georgia
-$361K -40,000 Closed
Brown Advisory
75
Brown Advisory
Maryland
-$336K -37,160 Closed

VTYX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2026, worth a combined $21K — down 100% from $472M a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of VTYX and 1 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $20.3K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $58.6M sold.

  • 1 institutional investor held Ventyx Biosciences (VTYX) as of Q1 2026, down from 139 in Q4 2025.
  • Funds reported $21K of Ventyx Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Ventyx Biosciences positions in Q1 2026 and 138 closed out, a net change of -137 holders.
  • The largest Ventyx Biosciences buyer in Q1 2026 was IFP Advisors, an estimated $20.3K added.
  • The largest Ventyx Biosciences seller in Q1 2026 was Affinity Asset Advisors, an estimated $58.6M sold.

Based on aggregated 13F filings for Q1 2026.